Cargando…

Sirolimus Conversion Efficacy for Graft Function Improvement and Histopathology in Renal Recipients with Mild to Moderate Renal Insufficiency

This study was designed to evaluate whether sirolimus (SRL) conversion effectively improves renal function and histopathology in calcineurin inhibitor (CNI)-treated renal recipients with mild to moderate renal insufficiency. SRL conversion from CNI was performed in patients who underwent kidney tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joo, Dong Jin, Yang, Chul Woo, Jeong, Hyeon Joo, Lim, Beom Jin, Huh, Kyu Ha, Chung, Byung Ha, Choi, Yeong Jin, Kang, Shin-Wook, Kim, Yu Seun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129197/ https://www.ncbi.nlm.nih.gov/pubmed/25120315 http://dx.doi.org/10.3346/jkms.2014.29.8.1069

Ejemplares similares

Association between post-transplant uric acid level and renal allograft fibrosis: Analysis using Banff pathologic scores from renal biopsies
por: Kim, Deok Gie, et al.
Publicado: (2018)

Sirolimus in renal transplant recipients with malignancies in Germany
por: Naik, Marcel G, et al.
Publicado: (2020)

Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus
por: Gallon, Lorenzo, et al.
Publicado: (2014)

A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk
por: Lee, Juhan, et al.
Publicado: (2015)

Comparison of Early and Late Conversion of Sirolimus in Experimental Model of Chronic Cyclosporine Nephropathy
por: Kim, Jin Young, et al.
Publicado: (2012)

Alloimmune haemolysis in a renal transplant recipient receiving sirolimus
por: Hedley, Adam J., et al.
Publicado: (2008)

Sirolimus-induced interstitial pneumonitis in a renal transplant recipient
por: Kanaan, Nada, et al.
Publicado: (2008)

Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
por: Lipska, Kasia J., et al.
Publicado: (2011)

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002)

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
por: Yu, Ji Hyun, et al.
Publicado: (2016)

Effect of sevoflurane on grafted kidney function in renal transplantation
por: Park, Jin Ha, et al.
Publicado: (2012)

Long-term compensation of renal function after donor nephrectomy
por: Lee, Yong Pyo, et al.
Publicado: (2020)

Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients
por: Li, Lung-Chih, et al.
Publicado: (2017)

The effect of ABCB1 polymorphism on sirolimus in renal transplant recipients: a meta-analysis
por: Shao, Shuai, et al.
Publicado: (2020)

Sirolimus in a Renal Transplant Recipient Infected With COVID-19: A Blessing in Disguise?
por: Talwar, Dhruv, et al.
Publicado: (2021)

Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients
por: Lee, Hae Min, et al.
Publicado: (2015)

Renal Histologic Parameters Influencing Postoperative Renal Function in Renal Cell Carcinoma Patients
por: Koh, Myoung Ju, et al.
Publicado: (2013)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation
por: Kasiske, Bertram L., et al.
Publicado: (2012)

Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
por: Foroutan, Naghmeh, et al.
Publicado: (2013)

CMV-associated adrenal insufficiency in a renal transplant recipient
por: Tejura, Nilesh, et al.
Publicado: (2017)

Cytomegalovirus-Induced Adrenal Insufficiency in a Renal Transplant Recipient
por: Ardalan, M., et al.
Publicado: (2009)

The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation
por: Lee, Juhan, et al.
Publicado: (2015)

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype
por: Carroll, Robert P., et al.
Publicado: (2013)

Refractory rickets caused by mild distal renal tubular acidosis
por: Lee, Ji-Ho, et al.
Publicado: (2013)

Safety and Efficacy of Conversion from Twice-Daily Tacrolimus to Once-Daily Tacrolimus One Month after Transplantation: Randomized Controlled Trial in Adult Renal Transplantation
por: Oh, Chang-Kwon, et al.
Publicado: (2014)

Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Predictive factors for the development of renal insufficiency following partial nephrectomy and subsequent renal function recovery: A multicenter retrospective study
por: Lee, Kwang Suk, et al.
Publicado: (2019)

Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effects
por: Abramowicz, Daniel, et al.
Publicado: (2008)

Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment
por: Lee, Jong Hoon, et al.
Publicado: (2013)

Nanomedicines in renal transplant rejection – focus on sirolimus
por: Shen, Li-Jiuan, et al.
Publicado: (2007)

Pregnancy in Renal Transplant Recipients: Histopathology Provides New Insight
por: Hendren, Elizabeth M., et al.
Publicado: (2021)

Impact of pretransplant rituximab induction on highly sensitized kidney recipients: comparison with non-rituximab group
por: Song, Young Hae, et al.
Publicado: (2012)

Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
por: Moon, Jong Joo, et al.
Publicado: (2021)

Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
por: Veroux, Massimiliano, et al.
Publicado: (2013)

CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
por: Li, Yi, et al.
Publicado: (2015)

The effects of addition of coenzyme Q10 to metformin on sirolimus-induced diabetes mellitus
por: Sun, In O, et al.
Publicado: (2019)

Renal tissue elasticity by acoustic radiation force impulse: A prospective study of healthy kidney donors
por: Lee, Alan, et al.
Publicado: (2021)

The Effect of Conversion from a Calcineurin Inhibitor to Sirolimus on Skin Cancer Reduction in Post-renal Transplantation Patients
por: Smith, Aaron, et al.
Publicado: (2017)

Establishment of a Model of Renal Impairment with Mild Renal Insufficiency Associated with Atrial Fibrillation in Canines
por: Liang, Zhuo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i2k6ejvk84g9ds02tk2aievbkb